Compare
Bryn Inc. vs Gartner Inc vs Franklin Covey Co vs Evolent Health, Inc.
| Latest fiscal year | Bryn Inc. BRRN | Gartner Inc IT | Franklin Covey Co FC | Evolent Health, Inc. EVH |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-08-31 | 2025-12-31 |
| Revenue | n/a | $6.50B | $267.07M | $1.88B |
| Revenue growth (YoY) | n/a | +3.7% | -7.0% | -26.6% |
| Gross margin | n/a | 68.8% | 76.2% | 21.3% (computed) |
| Operating margin | n/a | 15.8% | 2.1% | -21.9% |
| Net margin | n/a | 11.2% | 1.1% | -28.5% |
| Net income | -$40.0K | $729.23M | $3.07M | -$534.51M |
| EPS (Diluted) | $0.00 | $9.65 | $0.24 | -$5.07 |
| Operating cash flow | -$45.8K | $1.29B | $28.98M | $38.84M |
| Free cash flow | n/a | n/a | $20.72M | n/a |
| Cash & equivalents | $0 | $1.72B | $31.70M | $151.86M |
| Total assets | n/a | $8.09B | $242.91M | $1.90B |
| Total liabilities | $96.6K | $7.77B | $176.00M | $1.48B |
| Shareholders' equity | -$96.6K | $319.91M | $66.91M | $415.19M |
| Return on year-end equity | n/a | 228.0% | 4.6% | -128.7% |
| Shares outstanding | 419.98M | n/a | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Bryn Inc. | Gartner Inc | Franklin Covey Co | Evolent Health, Inc. |
|---|---|---|---|---|
| Latest | $40.9K Ended 2012-04-30 | $6.50B Ended 2025-12-31 | $267.07M Ended 2025-08-31 | $1.88B Ended 2025-12-31 |
| 1 year earlier | $19.9K Ended 2011-04-30 | $6.27B Ended 2024-12-31 | $287.23M Ended 2024-08-31 | $2.55B Ended 2024-12-31 |
| 2 years earlier | n/a | $5.91B Ended 2023-12-31 | $280.52M Ended 2023-08-31 | $1.96B Ended 2023-12-31 |
| 3 years earlier | n/a | $5.48B Ended 2022-12-31 | $262.84M Ended 2022-08-31 | $1.35B Ended 2022-12-31 |
| 4 years earlier | n/a | $4.73B Ended 2021-12-31 | $224.17M Ended 2021-08-31 | $907.96M Ended 2021-12-31 |